Biotech

All Articles

Acepodia, Pfizer click on all together for chemistry-based cell treatment

.Phone it a situation of excellent chemistry: Acepodia, a biotech based upon Nobel Prize-winning sci...

Praxis epilepsy medication decreases confiscations in phase 2 hearing

.Praxis Precision Medicines has actually scored an additional midphase win in epilepsy this year, wi...

Three execs surrender as Dyne articles blended records for DMD applicant

.After leaving a professional hold a number of years back, Dyne Therapy has exposed new period 1/2 r...

Arrowhead fires off period 3 information in rare metabolic health condition ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has actually shown its hand in advance of a prospective showdown along wi...

Pfizer, Valneva present lyme condition try effective for 2nd booster

.Pfizer as well as Valneva might have concerning two even more years to stand by just before they cr...

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Shop with Michelle Benz on the Future of Biotech.

.Let's study a chat with Ayla Ellison, Tough Biotech Managing Editor and also Michelle Benz as they ...

New data demonstrate how Bayer's asundexian failed to prevent strokes

.Bayer suspended the period 3 test for its own element XIa prevention asundexian late in 2014 after ...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS tests

.Sanofi is still bented on taking its multiple sclerosis (MS) med tolebrutinib to the FDA, executive...

Galapagos' stockpile as fund shows intent to mold its development

.Galapagos is happening under additional tension coming from capitalists. Having constructed a 9.9% ...

Cell- focused Sana gathers 1st CSO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings...